Literature DB >> 1384183

Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody.

T C Pearson1, J C Madsen, C P Larsen, P J Morris, K J Wood.   

Abstract

The T-cell-mediated immune response usually results in the rapid destruction of organ allografts transplanted between murine strains incompatible for major and minor histocompatibility antigens. This response may be modified by pretreatment with either donor-specific antigen or anti-CD4 monoclonal antibody. Previous work by others has shown that combined treatment of mice with soluble protein antigens and anti-CD4 monoclonal antibody can produce antigen-specific B cell unresponsiveness that continues long after the nonspecific immunosuppressive effect of the mAb treatment has resolved. Following this principle we have shown that adult C3H/He mice can be made specifically unresponsive to vascularized C57BL/10 cardiac allografts by pretreating the recipient with donor alloantigen under the cover of a brief course of mAb against CD4. A full-dose response analysis shows that the dose of mAb is critically important for the successful induction of tolerance. Tolerance induction using this protocol is dependent on treatment with donor major histocompatibility complex antigens and occurs in the presence of marked depletion but not complete elimination of the CD4+ T cell subset. The unresponsiveness to alloantigen is antigen specific, as determined by the ineffectiveness of third-party (C57BL/10) alloantigen when combined with anti-CD4 mAb to induce long-term survival of BALB/c allografts in C3H/He recipients. The tolerant state is specific and effective in the long-term as indicated by the specific acceptance of C57BL/10 skin grafts in recipients with surviving C57BL/10 cardiac allografts. This study provides a simple method for the successful induction of specific transplantation tolerance in the adult across a full H-2 major and minor antigen mismatch strain combination. The results illustrate the important role of the CD4 molecule in the T cell response to alloantigen in vivo and suggest possibilities for the therapeutic manipulation of complex immune reactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384183     DOI: 10.1097/00007890-199209000-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

1.  Prediction of graft prolongation by mixed lymphocyte culture following anti-CD4 monoclonal antibody treatment among different donor-recipient combinations.

Authors:  K Hamano; H Ito; B Shirasawa; H Gohra; T Katoh; Y Fujimura; K Esato
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  Advancing islet transplantation: from engraftment to the immune response.

Authors:  R F Gibly; J G Graham; X Luo; W L Lowe; B J Hering; L D Shea
Journal:  Diabetologia       Date:  2011-08-10       Impact factor: 10.122

3.  Natural Tregs, CD4+CD25+ inhibitory hybridomas, and their cell contact dependent suppression.

Authors:  Elizabeth H Field; Katarina Kulhankova; Mohamed E Nasr
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment.

Authors:  Ling Weng; Julian Dyson; Francesco Dazzi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

5.  CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis.

Authors:  Gregor Warnecke; Gang Feng; Ryoichi Goto; Satish N Nadig; Ross Francis; Kathryn J Wood; Andrew Bushell
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

Review 6.  Immunologic tolerance in renal transplantation.

Authors:  D A Shoskes
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

7.  Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4(+) T-cell mediated rejection.

Authors:  Robert J Plenter; Todd J Grazia; David P Nelson; Martin R Zamora; Ronald G Gill; Biagio A Pietra
Journal:  Cell Immunol       Date:  2014-12-06       Impact factor: 4.868

8.  Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells.

Authors:  S W Chung; R M Gorczynski; I Dziadkowiec; G A Levy
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

9.  Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.

Authors:  L Chatenoud; E Thervet; J Primo; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

10.  Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.

Authors:  A Räisänen-Sokolowski; P L Mottram; T Glysing-Jensen; A Satoskar; M E Russell
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.